HOME > 研究業績 > 2013年- 英語論文

2013年- 英語論文

1.Niu K, Guo H, Guo Y, Ebihara S, Asada M, Ohrui T, Furukawa K, Ichinose M, Yanai K, Kudo Y, Arai H, Okazaki T, Nagatomi R. Royal Jelly Prevents the Progression of Sarcopenia in Aged Mice In Vivo and In Vitro. J Gerontol A Biol Sci Med Sci. 2013 May 8.

2.Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yooshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Saijo Y, Hagiwara K, Morita S, Nukiwa T. Updated overall survival results froma a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Annals of Oncology 24:54-59, 2013.

3.Akishita M, Ishii S, Kojima T, Kozaki K, Kuzuya M, Arai H, Arai H, Eto M, Takahashi R, Endo H, Horie S, Ezawa K, Kawai S, Takehisa Y, Mikami H, Takegawa S, Morita A, Kamata M, Ouchi Y, Toba K. Priorities of healthcare outcomes for the elderly. J Am Med Dir Assoc, in press 2013

4.Daito H, Suzuki M, Shiihara J, ilgore P.E., Ohtomo H, Morimoto K, Ishida M, Kamigaki T, Oshitani H, Hashizume M, Endo W, Hagiwara K, Ariyoshi K, Okinaga S. Impact of the Tohoku earthquake ant tsunami on pneumonia hospitalisations and mortality among adults in northern Miyagi, Japan: a multicenter observational study. Thorax 0:1-7, 2013.

5.Akinori Miyashita1., Asako Koike2., Gyungah Jun3., Li-San Wang4, Satoshi Takahashi5, Etsuro Matsubara6, Takeshi Kawarabayashi6, Mikio Shoji6, Naoki Tomita7, Hiroyuki Arai7, Takashi Asada8, Yasuo Harigaya9, Masaki Ikeda10, Masakuni Amari10, Haruo Hanyu11, Susumu Higuchi12,Takeshi Ikeuchi13, Masatoyo Nishizawa13, Masaichi Suga14, Yasuhiro Kawase15, Hiroyasu Akatsu16, Kenji Kosaka16, Takayuki Yamamoto16, Masaki Imagawa17, Tsuyoshi Hamaguchi18, Masahito Yamada18, Takashi Moriaha19, Masatoshi Takeda19, Takeo Takao20, Kenji Nakata21, Yoshikatsu Fujisawa21, Ken Sasaki21, Ken Watanabe22, Kenji Nakashima23, Katsuya Urakami24, Terumi Ooya25,Mitsuo Takahashi26, Takefumi Yuzuriha27, Kayoko Serikawa28, Seishi Yoshimoto28, Ryuji Nakagawa28, Jong-Won Kim29, Chang-Seok Ki29, Hong-Hee Won29, Duk L. Na30, Sang Won Seo30, Inhee Mook-Jung31, The Alzheimer Disease Genetics Consortium, Peter St. George-Hyslop32, Richard Mayeux33, Jonathan L. Haines34, Margaret A. Pericak-Vance35, Makiko Yoshida2, Nao Nishida36,Katsushi Tokunaga36, Ken Yamamoto37, Shoji Tsuji38, Ichiro Kanazawa39, Yasuo Ihara40, Gerard D. Schellenberg4, Lindsay A. Farrer3,41"*,SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians. PlosOne, 2013

6.Mattson N. et al. CSF biomarker variability in the Alzheimer’s Association quality control program. Alzheimer’s & Dementia 9:251-261, 2013

7.Tetsuro Tago, Shozo Furumoto, Nobuyuki Okamura, Ryuichi Harada , Yoichi Ishikawa, Hiroyuki Arai, Kazuhiko Yanai, Ren Iwata, Yukitsuka Kudo Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives 1 for tau Imaging. Journal of Labelled Compounds and Radiopharmaceuticals、in press 2013

8.Harada R, Okamura N, Furumoto S, Yoshikawa T, Arai H, Yanai K, Kudo Y. Use of a Benzimidazole Derivative BF-188 in Fluorescence Multispectral Imaging for Selective Visualization of Tau Protein Fibrils in the Alzheimer's Disease Brain. Mol Imaging Biol. 2013 Jul 19. [Epub ahead of print]

9.Okamura N, Furumoto S, Harada R, Tago T, Yoshikawa T, Fodero-Tavoletti M, Mulligan RS, Villemagne VL, Akatsu H, Yamamoto T, Arai H, Iwata R, Yanai K, Kudo Y. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med. 2013 Aug;54(8):1420-7.

10.Shidahara M, Tashiro M, Okamura N, Furumoto S, Furukawa K, Watanuki S, Hiraoka K, Miyake M, Iwata R, Tamura H, Arai H, Kudo Y, Yanai K. Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans. EJNMMI Res. 2013 Apr 24;3(1):32.

11.Furumoto S, Okamura N, Furukawa K, Tashiro M, Ishikawa Y, Sugi K, Tomita
N, Waragai M, Harada R, Tago T, Iwata R, Yanai K, Arai H, Kudo Y. A 18F-labeled
BF-227 derivative as a potential radioligand for imaging dense amyloid
plaques by positron emission tomography. Mol Imaging Biol. 2013 Aug;15(4):497-506.

12.Yamane T, Ikari Y, Nishio T, Ishii K, Ishii K, Kato T, Ito K, Silverman DH, Senda M, Asada T, Arai H, Sugishita M, Iwatsubo T; the J-ADNI Study Group. Visual-Statistical Interpretation of 18F-FDG-PET Images for Characteristic Alzheimer Patterns in a Multicenter Study: Inter-Rater Concordance and Relationship to Automated Quantitative Evaluation. Am J Neuroradiol. 2013 Aug 1. [Epub ahead of print]

13.Furukawa K, Ootsuki M, Nitta A, Okinaga S, Kodama M, Arai H. Aggravation of Alzheimer's disease symptoms after the earthquake in Japan: A comparative analysis of subcategories. Geriatr Gerontol Int. 2013 Oct;13(4):1081-2.
14.Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T. MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease. J Alzheimers Dis. 2013 Oct 24. [Epub ahead of print]
15.Seki T, Kamiya T, Furukawa K, Azumi M, Ishizuka S, Takayama S, Nagase S, Arai H, Yamakuni T, Yaegashi N. Nobiletin-rich Citrus reticulata peels, a kampo medicine for Alzheimer's disease: a case series. Geriatr Gerontol Int. 2013 Jan;13(1):236-8.

16.Niu G, Arai H. et al. Coffee treatment prevents the progression of sarcopenia in aged mice in vivo and in vitro. Exp. Gerontology 2013